IRadimed Expects 2026 Revenue of $91.6M to $93.1M
IRadimed expects 2026 revenue of $91.6 million to $93.1 million, versus a FactSet estimate of $92.1 million.
Story updates
01:04:20 PM UTC
SquawkNews
iRadimed Corporation announced its financial results for the third quarter of 2026, reporting an adjusted earnings per share (EPS) of $0.55, which aligned with FactSet estimates. Alongside these results, the company provided updated financial guidance, projecting full-year 2026 revenue between $91.6 million and $93.1 million. For the fourth quarter of 2026, the company expects revenue in the range of $25.0 million to $26.5 million and an adjusted EPS between $0.57 and $0.61. Additionally, iRadimed anticipates a full-year 2026 adjusted EPS range of $2.07 to $2.11.